Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -36.75% is 47% above its 5-year average of -69.92%, near the high end of its 5-year range (-186.22%–4.15%).
47.02% above its 12-month average of -69.37%.
Reported quarterly return on assets; no daily interpolation. Q3 FY2026 (2026-06-30): -18.87%.
RETURN ON ASSETS (ROA)
-36.75%
RETURN ON ASSETS (ROA) AVG TTM
-69.37%
RETURN ON ASSETS (ROA) AVG 3Y
-96.71%
RETURN ON ASSETS (ROA) AVG 5Y
-69.92%
RETURN ON ASSETS (ROA) AVG 10Y
-44.62%
RETURN ON ASSETS (ROA) AVG 15Y
-9.43%
RETURN ON ASSETS (ROA) AVG 20Y
-3.76%
CURRENT VS TTM AVG
+47.02%
CURRENT VS 3Y AVG
+62.00%
CURRENT VS 5Y AVG
+47.44%
CURRENT VS 10Y AVG
+17.63%
CURRENT VS 15Y AVG
-289.80%
CURRENT VS 20Y AVG
-877.26%
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-13.90%
vs the sector median at left
Veru Inc.
Market Cap
$39.64M
Return on Assets (ROA)
-36.75%
TTM Avg
-69.37%
3Y Avg
-96.71%
5Y Avg
-69.92%
Market Cap
$38.78M
Return on Assets (ROA)
-53.81%
TTM Avg
-31.90%
3Y Avg
-23.26%
5Y Avg
-21.62%
Market Cap
$38.61M
Return on Assets (ROA)
-13.65%
TTM Avg
-40.30%
3Y Avg
-22.41%
5Y Avg
-15.81%
Market Cap
$37.93M
Return on Assets (ROA)
-26.45%
TTM Avg
-127.88%
3Y Avg
-142.31%
5Y Avg
-121.77%
Market Cap
$41.83M
Return on Assets (ROA)
-5.70%
TTM Avg
-13.47%
3Y Avg
-29.01%
5Y Avg
-32.57%
Market Cap
$41.95M
Return on Assets (ROA)
-57.95%
TTM Avg
4.78%
3Y Avg
-64.05%
5Y Avg
-66.64%
Market Cap
$42.26M
Return on Assets (ROA)
-40.69%
TTM Avg
-38.43%
3Y Avg
-19.21%
5Y Avg
-15.37%
Market Cap
$42.72M
Return on Assets (ROA)
-87.60%
TTM Avg
-55.36%
3Y Avg
-44.79%
5Y Avg
-43.77%
Market Cap
$42.83M
Return on Assets (ROA)
-128.10%
TTM Avg
-35.87%
3Y Avg
-35.25%
5Y Avg
-29.40%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Veru Inc. (VERU) | $39.64M | -36.75% | -69.37% | -96.71% | -69.92% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $38.78M | -53.81% | -31.90% | -23.26% | -21.62% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.61M | -13.65% | -40.30% | -22.41% | -15.81% |
| Incannex Healthcare Limited (IXHL)vs › | $37.93M | -26.45% | -127.88% | -142.31% | -121.77% |
| Precipio, Inc. (PRPO)vs › | $41.83M | -5.70% | -13.47% | -29.01% | -32.57% |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | -57.95% | 4.78% | -64.05% | -66.64% |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.26M | -40.69% | -38.43% | -19.21% | -15.37% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $42.72M | -87.60% | -55.36% | -44.79% | -43.77% |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | -128.10% | -35.87% | -35.25% | -29.40% |
| CVRx, Inc. (CVRX)vs › | $42.99M | -56.31% | -47.91% | -41.18% | -35.79% |
ROA
-36.8%
ROE
-48.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-09-30 | -76.17% |
| 2024-09-30 | -62.57% |
| 2023-09-30 | -186.22% |
| 2022-09-30 | -61.89% |
| 2021-09-30 | 4.15% |
| 2020-09-30 | -36.81% |
| 2019-09-30 | -22.41% |
| 2018-09-30 | -49.41% |
| 2017-09-30 | -11.96% |
| 2016-09-30 | 0.89% |
| 2015-09-30 | 11.60% |
| 2014-09-30 | 7.68% |
| 2013-09-30 | 40.78% |
| 2012-09-30 | 50.25% |
| 2011-09-30 | 27.77% |
| 2010-09-30 | 36.68% |
| 2009-09-30 | 35.25% |
| 2008-09-30 | 35.91% |
| 2007-09-30 | 15.13% |
| 2006-09-30 | 3.79% |
| 2005-09-30 | -23.87% |
| 2004-09-30 | -44.91% |
| 2003-09-30 | -47.07% |
| 2002-09-30 | -62.58% |
| 2001-09-30 | -27.04% |
| 2000-09-30 | -89.55% |
| 1999-09-30 | -57.63% |
| 1998-09-30 | -44.42% |
| 1997-09-30 | -67.26% |
| 1996-09-30 | -63.04% |
